Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 96

• Price / Volume Information    Yesterday's Closing Price: $8.68 Daily Weekly Monthly 20 Day Moving Average: 1,240,763 shares Shares Outstanding: 35.31 (millions) Market Capitalization: $306.52 (millions) Beta: 0.81 52 Week High: $18.23 52 Week Low: $8.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -21.80% -22.29% 12 Week -21.87% -25.66% Year To Date -27.91% -37.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 566 QUEENSBURY AVENUE - QUEENSBURY,NY 12804 USA ph: 518-743-8892 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director John R. Sylvester - Chairman of the Board Sandra Pennell - Chief Financial Officer Elizabeth Czerepak - Director Steven Salamon - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/05/26 Share - Related Items Shares Outstanding: 35.31 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.81 Market Capitalization: $306.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.13 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/05/26

• Fundamental Ratios P/E Current FY Estimate: 66.77 Trailing 12 Months: 51.06 PEG Ratio: - Price Ratios Price/Book: 2.67 Price/Cash Flow: - Price / Sales: 3.85 EPS Growth vs. Year Ago Period: 166.67% vs. Previous Quarter: -71.43% Sales Growth vs. Year Ago Period: 83.60% vs. Previous Quarter: -14.87% ROE 09/30/25 - 7.02 06/30/25 - 6.91 03/31/25 - -29.44 ROA 09/30/25 - 6.39 06/30/25 - 5.80 03/31/25 - -20.75 Current Ratio 09/30/25 - 15.06 06/30/25 - 10.88 03/31/25 - 15.95 Quick Ratio 09/30/25 - - 06/30/25 - 9.87 03/31/25 - 14.61 Operating Margin 09/30/25 - 8.13 06/30/25 - 6.45 03/31/25 - -22.11 Net Margin 09/30/25 - 1.50 06/30/25 - 3.18 03/31/25 - -26.38 Pre-Tax Margin 09/30/25 - 1.82 06/30/25 - 4.18 03/31/25 - -26.02 Book Value 09/30/25 - 3.25 06/30/25 - 3.01 03/31/25 - 2.40 Inventory Turnover 09/30/25 - 1.24 06/30/25 - 1.27 03/31/25 - 1.20 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©